Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 6/20 | 0.44 |
| ▸ | CA2 | P00918 | 6/20 | 0.44 |
| ▸ | CA9 | Q16790 | 6/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA6 | P23280 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14205809 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL13912052 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL200631 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL10436399 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL106029 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL200477 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL13912064 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL14578207 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL199009 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 | |
| SCHEMBL14205807 | 1.00 | THRB (0.53) | THRBTSHRLPAR3LPAR2LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3492526-B1 | RESIN COMPOSITION AND USE THEREOF | SUMITOMO CHEMICAL CO (JP) | 2025-02-19 | — | — | EP | disclosed |
| EP-4342958-A1 | HEAT STORAGE COMPOSITION | Sumitomo Chemical Company Limited (JP) | 2024-03-27 | — | — | EP | disclosed |
| US-11696954-B2 | Synthesis of spherical nucleic acids using lipophilic moieties | EXICURE OPERATING COMPANY (US) | 2023-07-11 | — | — | US | disclosed |
| US-11696954-B2 | Synthesis of spherical nucleic acids using lipophilic moieties | EXICURE OPERATING COMPANY (US) | 2023-07-11 | — | — | US | disclosed |
| EP-4159903-A1 | HEAT STORAGE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-04-05 | — | — | EP | disclosed |
| CN-115667599-A | Heat-accumulating composition | 住友化学株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-109642086-B | Resin composition and use thereof | 住友化学株式会社 | 2022-07-22 | — | — | CN | disclosed |
| US-20200188521-A1 | SYNTHESIS OF SPHERICAL NUCLEIC ACIDS USING LIPOPHILIC MOIETIES | EXICURE, INC. (US) | 2020-06-18 | — | — | US | disclosed |
| US-8486924-B2 | Taxane delivery system | CELATOR PHARMACEUTICALS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| US-8486924-B2 | Taxane delivery system | CELATOR PHARMACEUTICALS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| WO-2010111822-A1 | OLIGOCONDENSED PERYLENE BISIMIDES | BASF SE (DE) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010112452-A1 | OLIGOCONDENSED PERYLENE BISIMIDES | BASF SE (DE) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010104169-A1 | FLUORENE COMPOUND | 味の素株式会社 (JP) | 2010-09-16 | — | — | WO | disclosed |
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | US | disclosed |
| US-7531165-B2 | Hair cosmetic, aminocarboxylic acid amide and method for producing the same | KAO CORPORATION (JP) | 2009-05-12 | — | — | US | disclosed |
| US-7524486-B2 | Hair cosmetic, aminocarboxylic acid amide and method for producing the same | KAO CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| EP-2008319-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007116001-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | TDO2, C9, CYP3A43 | THRB 1203/4885TSHR 1062/4885LPAR3 3306/4885 |
| US-20200188521-A1 | SYNTHESIS OF SPHERICAL NUCLEIC ACIDS USING LIPOPHILIC MOIETIES | NCL, SARNP, SNRPA | THRB 3547/4885TSHR 2627/4885LPAR3 471/4885 |
| US-11696954-B2 | Synthesis of spherical nucleic acids using lipophilic moieties | NCL, SARNP, SNRPA | THRB 3547/4885TSHR 2627/4885LPAR3 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.